Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?

Prakash S. Masand, Sanjay Gupta, Thomas L. Schwartz, David Kaplan, Subhdeep Virk, Ahmad Hameed, Kari Lockwood

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Irritable bowel syndrome (IBS) is the most common disorder in patients seen by gastroenterologists. Twenty subjects with IBS diagnosed with the Rome criteria were treated for 12 weeks with 20-40 mg/day of paroxetine (mean dose = 31 mg/day). At baseline, 10 patients had a lifetime history of an anxiety disorder, and 10 patients did not have such a history. Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/abdominal distension. Paroxetine was very well tolerated.

Original languageEnglish (US)
Pages (from-to)451-455
Number of pages5
JournalPsychosomatics
Volume43
Issue number6
DOIs
StatePublished - Jan 1 2002

Fingerprint

Paroxetine
Preexisting Condition Coverage
Irritable Bowel Syndrome
Anxiety Disorders
Constipation
Abdominal Pain
Diarrhea
History
Syndrome

All Science Journal Classification (ASJC) codes

  • Arts and Humanities (miscellaneous)
  • Applied Psychology
  • Psychiatry and Mental health

Cite this

Masand, Prakash S. ; Gupta, Sanjay ; Schwartz, Thomas L. ; Kaplan, David ; Virk, Subhdeep ; Hameed, Ahmad ; Lockwood, Kari. / Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?. In: Psychosomatics. 2002 ; Vol. 43, No. 6. pp. 451-455.
@article{f7cac0be717f485fabbb2a9787b2e659,
title = "Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?",
abstract = "Irritable bowel syndrome (IBS) is the most common disorder in patients seen by gastroenterologists. Twenty subjects with IBS diagnosed with the Rome criteria were treated for 12 weeks with 20-40 mg/day of paroxetine (mean dose = 31 mg/day). At baseline, 10 patients had a lifetime history of an anxiety disorder, and 10 patients did not have such a history. Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/abdominal distension. Paroxetine was very well tolerated.",
author = "Masand, {Prakash S.} and Sanjay Gupta and Schwartz, {Thomas L.} and David Kaplan and Subhdeep Virk and Ahmad Hameed and Kari Lockwood",
year = "2002",
month = "1",
day = "1",
doi = "10.1176/appi.psy.43.6.451",
language = "English (US)",
volume = "43",
pages = "451--455",
journal = "Psychosomatics",
issn = "0033-3182",
publisher = "American Psychiatric Publishing Inc.",
number = "6",

}

Masand, PS, Gupta, S, Schwartz, TL, Kaplan, D, Virk, S, Hameed, A & Lockwood, K 2002, 'Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?', Psychosomatics, vol. 43, no. 6, pp. 451-455. https://doi.org/10.1176/appi.psy.43.6.451

Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome? / Masand, Prakash S.; Gupta, Sanjay; Schwartz, Thomas L.; Kaplan, David; Virk, Subhdeep; Hameed, Ahmad; Lockwood, Kari.

In: Psychosomatics, Vol. 43, No. 6, 01.01.2002, p. 451-455.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Does a preexisting anxiety disorder predict response to paroxetine in irritable bowel syndrome?

AU - Masand, Prakash S.

AU - Gupta, Sanjay

AU - Schwartz, Thomas L.

AU - Kaplan, David

AU - Virk, Subhdeep

AU - Hameed, Ahmad

AU - Lockwood, Kari

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Irritable bowel syndrome (IBS) is the most common disorder in patients seen by gastroenterologists. Twenty subjects with IBS diagnosed with the Rome criteria were treated for 12 weeks with 20-40 mg/day of paroxetine (mean dose = 31 mg/day). At baseline, 10 patients had a lifetime history of an anxiety disorder, and 10 patients did not have such a history. Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/abdominal distension. Paroxetine was very well tolerated.

AB - Irritable bowel syndrome (IBS) is the most common disorder in patients seen by gastroenterologists. Twenty subjects with IBS diagnosed with the Rome criteria were treated for 12 weeks with 20-40 mg/day of paroxetine (mean dose = 31 mg/day). At baseline, 10 patients had a lifetime history of an anxiety disorder, and 10 patients did not have such a history. Both groups had similar improvement in abdominal pain, constipation, diarrhea, incomplete emptying, and bloating/abdominal distension. Paroxetine was very well tolerated.

UR - http://www.scopus.com/inward/record.url?scp=0036840750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036840750&partnerID=8YFLogxK

U2 - 10.1176/appi.psy.43.6.451

DO - 10.1176/appi.psy.43.6.451

M3 - Article

C2 - 12444227

AN - SCOPUS:0036840750

VL - 43

SP - 451

EP - 455

JO - Psychosomatics

JF - Psychosomatics

SN - 0033-3182

IS - 6

ER -